Therefore, ERCC1 is considered to be one of the significant therapeutic target for lung cancer treatment, as targeting ERCC1 may possibly restore the therapeutic sensitivity to platinum-based chemicals [7]. The gene discussed is ERCC1; the disease is lung carcinoma.